학술논문
Incorporation of Ruxolitinib in the Management of Refractory/ Relapsed Hodgkin Lymphoma: Where Do We Stand?
Document Type
Letter
Author
Source
In: Clinical Hematology International . (Clinical Hematology International, 2023, 5(4):1-4)
Subject
Language
English
ISSN
25900048